Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
about
Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Comparison of Treatment Persis ...... ational Health Care Databases.
@en
Comparison of Treatment Persis ...... ational Health Care Databases.
@nl
type
label
Comparison of Treatment Persis ...... ational Health Care Databases.
@en
Comparison of Treatment Persis ...... ational Health Care Databases.
@nl
prefLabel
Comparison of Treatment Persis ...... ational Health Care Databases.
@en
Comparison of Treatment Persis ...... ational Health Care Databases.
@nl
P2860
P50
P921
P356
P1433
P1476
Comparison of Treatment Persis ...... ational Health Care Databases.
@en
P2093
Cécile Billionnet
Joshua J Gagne
P2860
P356
10.1002/PHAR.2046
P407
P577
2017-10-13T00:00:00Z